Tag: Long Arg3 IGF-1 analog

  • IGF-1 LR3

    Long Arg3 IGF-1 analog

    A long-acting analog of IGF-1 with N-terminal extension and Arg3 substitution that reduces IGFBP binding and extends plasma half-life.

    Abstract

    IGF-1 LR3 (Long R3 IGF-1; CAS 946870-92-4; molecular weight 9111) is a recombinant analog of human IGF-1 with two structural modifications: a 13-residue N-terminal extension derived from the methionyl-N-terminal region of porcine GH, and substitution of arginine for glutamic acid at position 3. Both modifications reduce binding to IGF binding proteins (IGFBPs), which extends the plasma half-life and increases free bioavailable IGF-1 activity at IGF-1 receptors. The compound was originally developed for cell culture applications (mammalian cell growth media); research-grade availability supports investigational use. Pharmacokinetics: plasma half-life approximately 20 to 30 hours (versus 12 to 15 hours for native IGF-1). The compound is sold as a research chemical at concentrations typically 1 mg/mL.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.